TERC rs12696304 was associated with a decreased probability of the occurrence of MS in males according to the codominant, dominant, and additive models (5.5-fold (OR: 0.182, (95% CI: 0.037–0.894), p = 0.036), 2-fold (OR =0.507, (95% CI: 0.284–0.903), p = 0.021), and 1.9-fold (OR: 0.515, (95% CI: 0.314–0.845), p = 0.009). The gene discussed is TERC; the disease is myeloid sarcoma.